Usefulness of Proton and Phosphorus MR Spectroscopic Imaging for Early Diagnosis of Parkinson's Disease

GBA-associated PD: Neurodegeneration, altered membrane metabolism, and lack of energy failure

(2012) K. Brockmann et al.   NEUROLOGY

Elevated Pontine and Putamenal GABA Levels in Mild-Moderate Parkinson Disease Detected by 7 Tesla Proton MRS

(2012) Uzay E. Emir et al.   PLoS One

Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson's Disease

(2012) O. Cooper et al.   Science Translational Medicine

Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson’s disease

(2011) Adriane Gröger et al.   EUROPEAN RADIOLOGY

Multinuclear Magnetic Resonance Spectroscopy for in Vivo Assessment of Mitochondrial Dysfunction in Parkinson's Disease

(2010) Claire Henchcliffe et al.   Annals of the New York Academy of Sciences

Quantitative magnetic resonance spectroscopic imaging in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy

(2010) C. A. Guevara et al.   EUROPEAN JOURNAL OF NEUROLOGY

Brain N-acetylaspartate is Reduced in Parkinson Disease With Dementia

(2009) Henry Randall Griffith et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease

(2009) Elke Hattingen et al.   BRAIN

Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease

(2009) M. Flint Beal   PARKINSONISM & RELATED DISORDERS

Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: anin vivo3.0 T1H MRS imaging study

(2008) Sanjay J. Mathew et al.   NMR IN BIOMEDICINE